Redux Removed From Exchange
In September 1997, the FDA arise that the biologic Redux was accepting pulled from the market.
Redux was assigned for appetence abolishment for weight loss. The drug's maker voluntarily agreed to abandon it.
The FDA action was based on accusation from doctors who had evaluated patients demography this drug. The accusation advertise that about 30% of patients who acclimatized a amore ultrasound, declared an echocardiogram, had abnormal amore valves even acceptance they had no symptoms. This is a abounding academy than accustomed allocation of abnormalities, according to the FDA.